BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35512076)

  • 1. Expression of S100A9 and KL-6 in common interstitial lung diseases.
    Lin L; Zhao Y; Li Z; Li Y; Wang W; Kang J; Wang Q
    Medicine (Baltimore); 2022 Apr; 101(17):e29198. PubMed ID: 35512076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The expression and clinical role of KL-6 in serum and BALF of patients with different diffuse interstitial lung diseases].
    Zhu C; Zhao YB; Kong LF; Li ZH; Kang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2016 Feb; 39(2):93-7. PubMed ID: 26879611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100 Calcium-Binding Protein A9, a Potential Novel Diagnostic Biomarker for Idiopathic Pulmonary Fibrosis.
    Lee JU; Kim MK; Kim MS; Lee SJ; Park SL; Chang HS; Park JS; Park CS
    J Korean Med Sci; 2024 Jan; 39(1):e13. PubMed ID: 38193329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
    Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
    Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases.
    Korthagen NM; Nagtegaal MM; van Moorsel CH; Kazemier KM; van den Bosch JM; Grutters JC
    Clin Exp Immunol; 2010 Aug; 161(2):342-7. PubMed ID: 20550547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local and Systemic Concentrations of Pattern Recognition Receptors of the Lectin Pathway of Complement in a Cohort of Patients With Interstitial Lung Diseases.
    Vogt S; Trendelenburg M; Tamm M; Stolz D; Hostettler KE; Osthoff M
    Front Immunol; 2020; 11():562564. PubMed ID: 33101280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics and clinical significance of pulmonary function test and KL-6 in ASSD-ILD and IPF].
    Sun D; Cheng Z; Jiang TC; Li PF; Jia LQ; Wang TT; Zheng CP; Li Y; Duo MJ
    Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(10):748-752. PubMed ID: 32192286
    [No Abstract]   [Full Text] [Related]  

  • 8. S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis.
    Hara A; Sakamoto N; Ishimatsu Y; Kakugawa T; Nakashima S; Hara S; Adachi M; Fujita H; Mukae H; Kohno S
    Respir Med; 2012 Apr; 106(4):571-80. PubMed ID: 22209187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calgranulin B and KL-6 in Bronchoalveolar Lavage of Patients with IPF and NSIP.
    Bennett D; Salvini M; Fui A; Cillis G; Cameli P; Mazzei MA; Fossi A; Refini RM; Rottoli P
    Inflammation; 2019 Apr; 42(2):463-470. PubMed ID: 30680696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Krebs von den Lungen-6 level as a diagnostic biomarker for interstitial lung disease in Chinese patients.
    Hu Y; Wang LS; Jin YP; Du SS; Du YK; He X; Weng D; Zhou Y; Li QH; Shen L; Zhang F; Su YL; Sun XL; Ding JJ; Zhang WH; Cai HR; Dai HP; Dai JH; Li HP
    Clin Respir J; 2017 May; 11(3):337-345. PubMed ID: 26077281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases.
    Vasakova M; Sterclova M; Kolesar L; Slavcev A; Pohunek P; Sulc J; Skibova J; Striz I
    Scand J Immunol; 2009 Mar; 69(3):268-74. PubMed ID: 19281539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
    Xue M; Guo Z; Cai C; Sun B; Wang H
    Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
    Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
    Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum and bronchoalveolar lavage fluid levels of soluble B7H3 in patients with interstitial lung diseases.
    Nakashima T; Omori K; Namba M; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Iwamoto H; Fujitaka K; Hamada H; Hattori N
    Respir Med; 2023 Jun; 212():107224. PubMed ID: 37003499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Utility of Bronchoalveolar Lavage Neutrophilia and Biomarkers for Evaluating Severity of Chronic Fibrosing Interstitial Lung Diseases.
    Shadrach BJ; Dutt N; Elhence P; Banerjee M; Chauhan NK; Jalandra RN; Garg MK; Garg P; Tandon A; Shishir S; Kochar R; Chhatwani B; Pareek P; Parrikar A
    Cureus; 2023 Jul; 15(7):e42162. PubMed ID: 37602059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical importance of bronchoalveolar lavage fluid and blood cytokines, surfactant protein D, and Kerbs von Lungren 6 antigen in idiopathic pulmonary alveolar proteinosis.
    Lin FC; Chen YC; Chang SC
    Mayo Clin Proc; 2008 Dec; 83(12):1344-9. PubMed ID: 19046553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAL biomarkers' panel for differential diagnosis of interstitial lung diseases.
    d'Alessandro M; Carleo A; Cameli P; Bergantini L; Perrone A; Vietri L; Lanzarone N; Vagaggini C; Sestini P; Bargagli E
    Clin Exp Med; 2020 May; 20(2):207-216. PubMed ID: 31970550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases.
    Suga M; Iyonaga K; Ichiyasu H; Saita N; Yamasaki H; Ando M
    Eur Respir J; 1999 Aug; 14(2):376-82. PubMed ID: 10515417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease.
    Kohno N; Awaya Y; Oyama T; Yamakido M; Akiyama M; Inoue Y; Yokoyama A; Hamada H; Fujioka S; Hiwada K
    Am Rev Respir Dis; 1993 Sep; 148(3):637-42. PubMed ID: 8368634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulatory Serum Krebs von Den Lungen-6 and Surfactant Protein-D Concentrations Predict Interstitial Lung Disease Progression and Mortality.
    Rai M; Parthasarathi A; Beeraka NM; Kaleem Ullah M; Malamardi S; Padukudru S; Siddaiah JB; Uthaiah CA; Vishwanath P; Chaya SK; Ramaswamy S; Upadhyay S; Ganguly K; Mahesh PA
    Cells; 2023 Apr; 12(9):. PubMed ID: 37174681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.